Preliminary construction of value judgment framework of precision medicine technology_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Jinsui ^1,2,3 , QIU Yingpeng ^2,3 , XIAO Yue ^2,3 , LIU Yuehua ^2,3 ,  ZHAO Kun ^2,3

1. School of Public Health, Fudan University, Shanghai 200032, P.R. China;
2. China National Health Development Research Center, Beijing 100191, P.R. China;
3. China National Center for Drug and Health Technology Assessment, Beijing 100191, P.R. China;

Corresponding author：

ZHAO Kun, Email: zk317@yahoo.com

Keywords：

Precision medicine; Value framework; Expert consultation; Indicator system

DOI：

10.7507/1672-2531.202001061

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To initially construct a scientific, reasonable and precision medicine technology value judgment framework suitable for China’s national conditions based on expert consultation method, so as to provide scientific value judgment system support for China's medical insurance decision-making.Methods The preliminary evaluation indicator system for precision medicine technology value was established by using literature analysis and expert consultation method, and the direct weighting method was used to determine the indicators weight.Results After two rounds of expert consultation, an indicator system suitable for the value judgment of precision medicine technology in China was constructed, including 5 primary indicators (health needs, health effects, economics, innovation and suitability) and 14 secondary indicators. Each indicator was weighted according to importance.Conclusions A set of precision medicine value judgment indicator system suitable for China has been initially established, which lays a certain foundation for further measurement research of the indicator system and provides a scientific basis for medical insurance decision-making.

Citation： ZHANG Jinsui, QIU Yingpeng, XIAO Yue, LIU Yuehua, ZHAO Kun. Preliminary construction of value judgment framework of precision medicine technology. Chinese Journal of Evidence-Based Medicine, 2020, 20(8): 918-922. doi: 10.7507/1672-2531.202001061 Copy

1.	National Library of Medicine. What is precision medicine? Available from: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition.
2.	Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med, 2012, 366(6): 489-491.
3.	Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med, 2015, 372(23): 2229-2234.
4.	张华, 詹启敏. 引领全球精准医学发展推动健康中国 2030 建设. 中华骨与关节外科杂志, 2017, 10(6): 474-481.
5.	崔孟珣, 彭奕, 赵瑾, 等. 国内外新药进医保目录的比较研究及对我国相关政策建议. 药学实践杂志, 2011, 29(3): 226-228.
6.	段晓托, 连桂玉, 贾耀珠. 我国创新药进入医保目录的障碍与对策. 中国药房, 2017, 28(4): 455-457.
7.	焦怡琳, 王吉春, 张群, 等. 中国在精准医学领域面临的机遇与挑战. 中国公共卫生管理, 2015, 31(5): 601-603.
8.	Emery JCH, Zwicker JD. Innovation, productivity, and pricing: Capturing value from precision medicine technology in Canada. Healthc Manage Forum, 2017, 30(4): 197-199.
9.	叶瑶. 基于德尔菲法的困境儿童社会救助保护项目评估指标体系开发研究. 北京: 中国青年政治学院, 2016.
10.	王芳. 社区卫生服务绩效评价指标体系研究. 武汉: 华中科技大学, 2006.
11.	吕亚兰. 适宜卫生技术评估指标体系及评估方法研究. 重庆: 重庆医科大学, 2013.
12.	张金穗, 邱英鹏, 肖月, 等. 精准医学技术的国际价值判断框架指标构建及归纳. 中国卫生经济, 2020, 39(1): 26-29.
13.	曾光. 现代流行病学方法与应用. 北京: 北京医科大学中国协和医科大学联合出版社, 1994.
14.	郭祖德, 周萍, 夏志远, 等. 加拿大卫生技术评估机构研究:以加拿大药物和卫生技术局为例. 中国卫生资源, 2016, 19(3): 187-190.
15.	陈晓炜, 陈钱, 耿劲松, 等. 多准则决策分析应用于医疗保险报销的系统评价. 中国卫生资源, 2018, 21(3): 218-223.
16.	Hailey D. Toward transparency in health technology assessment: a checklist for HTA reports. Int J Technol Assess Health Care, 2003, 19(1): 1-7.
17.	嵇承栋, 朱琳懿, 万悦竹, 等. 国际卫生技术评估机构协作网卫生技术评估报告清单解读. 中国循证医学杂志, 2016, 16(3): 369-372.

1. National Library of Medicine. What is precision medicine? Available from: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition.
2. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med, 2012, 366(6): 489-491.
3. Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med, 2015, 372(23): 2229-2234.
4. 张华, 詹启敏. 引领全球精准医学发展推动健康中国 2030 建设. 中华骨与关节外科杂志, 2017, 10(6): 474-481.
5. 崔孟珣, 彭奕, 赵瑾, 等. 国内外新药进医保目录的比较研究及对我国相关政策建议. 药学实践杂志, 2011, 29(3): 226-228.
6. 段晓托, 连桂玉, 贾耀珠. 我国创新药进入医保目录的障碍与对策. 中国药房, 2017, 28(4): 455-457.
7. 焦怡琳, 王吉春, 张群, 等. 中国在精准医学领域面临的机遇与挑战. 中国公共卫生管理, 2015, 31(5): 601-603.
8. Emery JCH, Zwicker JD. Innovation, productivity, and pricing: Capturing value from precision medicine technology in Canada. Healthc Manage Forum, 2017, 30(4): 197-199.
9. 叶瑶. 基于德尔菲法的困境儿童社会救助保护项目评估指标体系开发研究. 北京: 中国青年政治学院, 2016.
10. 王芳. 社区卫生服务绩效评价指标体系研究. 武汉: 华中科技大学, 2006.
11. 吕亚兰. 适宜卫生技术评估指标体系及评估方法研究. 重庆: 重庆医科大学, 2013.
12. 张金穗, 邱英鹏, 肖月, 等. 精准医学技术的国际价值判断框架指标构建及归纳. 中国卫生经济, 2020, 39(1): 26-29.
13. 曾光. 现代流行病学方法与应用. 北京: 北京医科大学中国协和医科大学联合出版社, 1994.
14. 郭祖德, 周萍, 夏志远, 等. 加拿大卫生技术评估机构研究:以加拿大药物和卫生技术局为例. 中国卫生资源, 2016, 19(3): 187-190.
15. 陈晓炜, 陈钱, 耿劲松, 等. 多准则决策分析应用于医疗保险报销的系统评价. 中国卫生资源, 2018, 21(3): 218-223.
16. Hailey D. Toward transparency in health technology assessment: a checklist for HTA reports. Int J Technol Assess Health Care, 2003, 19(1): 1-7.
17. 嵇承栋, 朱琳懿, 万悦竹, 等. 国际卫生技术评估机构协作网卫生技术评估报告清单解读. 中国循证医学杂志, 2016, 16(3): 369-372.

Chinese Journal of Evidence-Based Medicine

Preliminary construction of value judgment framework of precision medicine technology

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content